An adaptogenic berry used for centuries in Chinese medicine to boost energy, protect the liver, and sharpen focus. It's one of the few adaptogens with solid liver-protective evidence.
Reviewed March 2026
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Schizandra has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Schizandra and schisandra are two spellings for Schisandra chinensis, so both deliver the same lignan chemistry. Lignan intake from the two entries is one total.
Rhodiola and schisandra are two of the three components of the long-standing adaptogen triad used for normal stamina under stress. Rhodiola acts on catecholamine turnover, schisandra on liver antioxidant capacity.
Eleuthero completes the traditional three-herb adaptogen combination with rhodiola and schisandra. The three chemistries are distinct and the formulation practice is decades old.
Withanolides moderate the normal stress hormone response while schisandra lignans support liver antioxidant capacity and alertness. The two are combined routinely and act on different systems.
Panax saponins and schisandra lignans are paired in traditional tonic formulas for normal energy. Schisandra also slows clearance of some co-taken actives, so ginsenoside exposure can run a little higher.
Schisandra lignans induce phase II conjugating enzymes while silymarin stabilises membranes and supports glutathione. The two cover different steps of normal liver handling of compounds.
Schisandra raises glutathione S-transferase activity, and NAC supplies the cysteine needed to keep the glutathione pool full. Enzyme induction without substrate would run into a ceiling.
The conjugation enzymes schisandra lignans upregulate use glutathione as their working substrate. Supplying it alongside pairs the enzyme with the material it consumes.
Schisandra lignans inhibit CYP3A4 and P-glycoprotein, both of which limit berberine's very low oral exposure. Co-dosing raises berberine blood levels above what the same dose alone would give.
Curcumin is cleared rapidly by phase II conjugation and efflux transporters that schisandra lignans slow. Exposure to curcumin therefore runs higher in the pairing than the label dose suggests.
Piperine and schisandra lignans both inhibit CYP3A4 and P-glycoprotein, so stacking them compounds the same brake on clearance. Exposure to every other lipophilic active in the formula can rise more than intended.
St John's wort induces CYP3A4 and P-glycoprotein while schisandra inhibits them, so the two pull the clearance of co-taken compounds in opposite directions. The net exposure of anything else in the formula becomes unpredictable.
Alpha lipoic acid regenerates reduced glutathione, the substrate for the conjugation enzymes schisandra upregulates. The pairing keeps the induced pathway supplied.
Cordyceps and schisandra appear together in traditional and modern adaptogen blends aimed at exertion tolerance. The pairing is a compositional convention with long use rather than a measured combination. No trial isolates the contribution of either.
Ling zhi and wu wei zi are classical companions in Chinese formulae directed at calm and endurance. Their chemistry is unrelated: schisandra supplies dibenzocyclooctadiene lignans, reishi supplies triterpenes and beta-glucans. The pairing adds distinct compound classes.
Huang qi is one of the most common co-ingredients in formulae containing schisandra berry. The relationship is documented in herbal texts and in commercial blends. Nothing separates a pairwise effect from the whole formula.
Gan cao is the standard harmonising herb added to multi-herb decoctions containing schisandra. It also contributes glycyrrhizin, which has its own effects on mineral handling at sustained intakes. That is a trade-off worth stating rather than a pure addition.
Dang gui and schisandra co-occur in classical tonic formulae. The record is compositional practice recorded in herbal literature. There is no isolated measurement of the pair.
Bacopa and schisandra are each studied against cognitive testing measures, by different proposed routes. Combining them stacks inputs on the same class of measurement. Cognitive test scores are markers of performance under test conditions, not a clinical outcome.
L-theanine is associated with a calm-alert subjective state and schisandra is used in adaptogen blends for the same reason. Products combine them for that overlap. There is no combination trial, and both endpoints in this space are self-reported.
Adaptogen blends often pair schisandra with caffeine so that the stimulant carries the acute effect. The interaction is formulation convention, not a measured pharmacological synergy. Caffeine dose is what dominates the subjective result.
Tyrosine is the precursor for dopamine, noradrenaline and adrenaline, and its availability constrains synthesis under sustained demand. Adaptogen blends built around fatigue and alertness pair it with schisandra for that reason. The precursor step is settled biochemistry; the combination itself is not measured.
Glycine is one of the three amino acids ligated into glutathione, and the hepatic literature on schisandra centres on glutathione status and phase II handling. Supplying the precursor addresses a different constraint than the herb does. Reported as biochemistry rather than as a measured pairing.
Cysteine availability is the usual limit on how much glutathione the liver can build. Schisandra lignans are described as influencing phase II enzyme expression rather than supplying substrate. The two act on separate constraints in the same system.
Betaine donates a methyl group to remethylate homocysteine to methionine, which feeds the S-adenosylmethionine pool that supports hepatic conjugation reactions. Schisandra is used in the same context for its effect on hepatic enzyme handling. The methyl supply side is settled biochemistry.
Choline supports the export of lipid from the liver as phosphatidylcholine and is oxidised to betaine as a methyl donor. Schisandra formulations aimed at normal liver function commonly include it. The choline role is textbook nutrition, not a combination finding.
Phosphatidylcholine is the required phospholipid for assembling very low density lipoproteins that carry triglyceride out of the liver. It is a structural contribution, distinct from the enzyme-expression effects described for schisandra lignans. The two are complementary rather than overlapping.
Glutathione peroxidases require a selenocysteine residue at their active site, so selenium status sets a ceiling on how much of the glutathione pool can be used for peroxide handling. Schisandra is studied in the same antioxidant context. Cofactor sufficiency is a precondition, not an additive effect.
Ascorbate operates in the aqueous phase and regenerates tocopheryl radicals at membrane surfaces. Schisandra lignans are lipophilic and behave differently. Combining a water-phase and a lipid-phase agent is standard antioxidant formulation logic.
Artichoke leaf is used for its effect on bile flow, schisandra for hepatic enzyme handling. Products aimed at supporting normal liver function commonly carry both. The pairing is convention with distinct rationale for each, not a measured combination.
Dandelion root appears alongside schisandra in Western herbal liver-support blends. The rationale for each differs and neither has been isolated within the blend. Recorded here as compositional practice.
Ginkgo and schisandra are combined in products targeting cognitive test measures. Their proposed routes differ. Evidence for the pair is absent and each ingredient's own literature reports test-condition markers.
Hou po and wu wei zi co-occur in classical formulae and in modern stress-directed blends. The pairing is compositional. Magnolia bark also carries its own sedative-leaning constituents, which is worth stating when the two are stacked.
Turkey tail supplies polysaccharide fractions while schisandra supplies lignans, so the two occupy different compound classes in a blend. The pairing is formulation practice. No combination measurement exists.
Talk to a doctor before taking Schizandra if any of these apply to you: May interact with liver-metabolized drugs, Not recommended during pregnancy. These are flags to check first, not effects Schizandra is known to cause.
Not medical advice. Show the label to your pharmacist.The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
1 source behind our Schizandra verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
Read this carefully. These are 39 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Schizandra is, not how risky it is. A report is not proof Schizandra caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.